Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sana Biotechnology (SANA)
NASDAQ:SANA
Sana Biotechnology (SANA) Stock Price & Analysis
213 Followers
SANA Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.75 - $12.00
Previous Close$8.73
Volume1.26M
Average Volume (3M)1.91M
Market Cap
$1.93B
Enterprise Value$1.83B
Total Cash (Recent Filing)$205.19M
Total Debt (Recent Filing)$104.10M
Price to Earnings (P/E)-5.7
Beta2.41
Next Earnings
Aug 01, 2024EPS Estimate
-$0.28Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.53
Shares Outstanding221,502,908
10 Day Avg. Volume2,136,586
30 Day Avg. Volume1,910,019
Standard Deviation0.27
R-Squared0.09
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)21.60
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-9.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-9.69
Forecast
1Y Price Target
$12.25Price Target Upside40.32% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Sana Biotechnology News
PremiumCompany Announcements
Sana Biotechnology EVP and President of R&D Resigns
Bulls Say, Bears Say
Bulls Say
Clinical TrialsSana Biotechnology's stock may rise as four clinical programs are poised to release data, potentially serving as catalysts for growth.
Product EfficacyEncouraging initial data showing a high response rate and clean safety profile for Sana's hypoimmune platform could attract investor optimism.
Regulatory MilestonesThe FDA's acceptance of the IND for SC262 allows Sana Biotechnology to pursue new treatments, potentially driving stock value upward.
Bears Say
Financial PerformanceSana reported no revenues and a 4Q23 EPS of ($0.45), indicating financial losses.
Operational CostsReported no revenues for 4Q23 with higher than expected SG&A expenses.
Stock PerformanceExpected share price return -20.3%.
---
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
SANA FAQ
What was Sana Biotechnology’s price range in the past 12 months?
Sana Biotechnology lowest stock price was $2.75 and its highest was $12.00 in the past 12 months.
What is Sana Biotechnology’s market cap?
Currently, no data Available
When is Sana Biotechnology’s upcoming earnings report date?
Sana Biotechnology’s upcoming earnings report date is Aug 01, 2024 which is in 74 days.
How were Sana Biotechnology’s earnings last quarter?
Sana Biotechnology released its earnings results on May 08, 2024. The company reported -$0.49 earnings per share for the quarter, missing the consensus estimate of -$0.301 by -$0.189.
Is Sana Biotechnology overvalued?
According to Wall Street analysts Sana Biotechnology’s price is currently Undervalued.
Does Sana Biotechnology pay dividends?
Sana Biotechnology does not currently pay dividends.
What is Sana Biotechnology’s EPS estimate?
Sana Biotechnology’s EPS estimate is -$0.28.
How many shares outstanding does Sana Biotechnology have?
Sana Biotechnology has 221,502,910 shares outstanding.
What happened to Sana Biotechnology’s price movement after its last earnings report?
Sana Biotechnology reported an EPS of -$0.49 in its last earnings report, missing expectations of -$0.301. Following the earnings report the stock price went down -20.969%.
Which hedge fund is a major shareholder of Sana Biotechnology?
Among the largest hedge funds holding Sana Biotechnology’s share is Flagship Pioneering Inc.. It holds Sana Biotechnology’s shares valued at 102M.
---
Sana Biotechnology Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$12.25 (40.32% Upside)
$12.25 (40.32% Upside)
Blogger Sentiment
Bullish
SANA Sentiment 66%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 303.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $236.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.1%
Last 30 Days ▼ 2.9%
Last 30 Days ▼ 2.9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
16.71%
12-Months-Change
Fundamentals
Return on Equity
-76.82%
Trailing 12-Months
Asset Growth
-8.78%
Trailing 12-Months
Company Description
Sana Biotechnology
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases.
---
SANA Stock 12 Month Forecast
Average Price Target
$12.25
▲(40.32% Upside)
Technical Analysis
Best Analysts Covering SANA
1 Year
1 Year Success Rate
6/7 ratings generated profit
1 Year Average Return
+81.30%
reiterated a buy rating 10 days ago
Copying Reni Benjamin's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +81.30% per trade.
---